Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 19: 904-907, 1973;
This Article
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Denton, M. D.
Right arrow Articles by Smith, F. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Denton, M. D.
Right arrow Articles by Smith, F. G.

Clinical Chemistry, Vol 19, 904-907, Copyright © 1973 by the American Association for Clinical Chemistry

Gas-Chromatographic Measurement of Urinary Polyamines in Cancer Patients

M. Drue Denton 1, Helen S. Glazer 1, David C. Zellner 1, and Frank G. Smith 1

1 Hematology Division, Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio 45229.

The polyamines, spermidine and spermine, and the precursor diamine, putrescine, may have an important role in control of cellular growth because of their interaction with nucleic acid structure, function, and synthesis. We have developed a quantitative gas-chromatographic procedure for measuring polyamines and have measured their urinary excretion by cancer patients and noncancerous patients. Marked variations in values obtained during therapy and in response to some other variables are described. Both hydrolyzed and nonhydrolyzed urine samples have been examined, in order to quantitate both total and free polyamine and putrescine excretions. The potential clinical importance of these studies and the application of other instrumentation such as mass spectroscopy to improve the specificity and sensitivity of this method are discussed.


Key Words: spermidine, spermine, putrescine • diagnosis and prognosis of cancer

Submitted on April 24, 1973
Accepted on June 7, 1973






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1973 by the American Association for Clinical Chemistry.